Shari B Libicki

Title: The Innovations of Shari B. Libicki: Pioneering Transdermal Drug Delivery Systems

Introduction: Shari B. Libicki is an accomplished inventor based in Palo Alto, California, recognized for her impactful contributions to the field of pharmaceuticals. With three patents to her name, her work focuses on advanced drug delivery systems, particularly in transdermal applications.

Latest Patents: One of Libicki's notable patents is for a transdermal drug composition with dual permeation enhancers. This innovative dosage form is designed to coadminister a drug along with two percutaneous absorption enhancers, optimizing the delivery of medication through the skin. Another significant patent involves a transdermal delivery system for progesterone and estradiol esters. This system utilizes a polymer matrix to ensure effective administration of these critical hormones, either alone or in combination, promoting enhanced absorption rates.

Career Highlights: Shari B. Libicki is affiliated with Alza Corporation, a prominent company in the pharmaceutical industry known for developing innovative drug delivery technologies. Throughout her career, Libicki has focused on improving patient outcomes through efficient drug delivery systems, making her an influential figure in her field.

Collaborations: In her role at Alza Corporation, Libicki collaborates with esteemed colleagues such as David J. Enscore and Yu-Ling Cheng. Together, they contribute to the development of cutting-edge technologies that address various healthcare needs and improve the efficacy of pharmaceutical treatments.

Conclusion: Shari B. Libicki's work exemplifies the spirit of innovation in the pharmaceutical industry. Her dedication to advancing transdermal drug delivery systems showcases her commitment to enhancing healthcare solutions. With multiple patents under her belt, Libicki continues to pave the way for future advancements in drug delivery technology.